The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
ArticleNo Access

Issues in the Treatment of Chronic Mental Patients

Published Online:https://doi.org/10.1176/ps.35.12.1189

In the conference report on new approaches to the treatment of chronic patients (October 1984 issue of H&CP, page 989), the results of one study discussed by John M. Kane, M.D., were cited incorrectly. They should have read, "7 percent of those who received the standard dose relapsed, compared with 56 percent of those who received the lowered dose." The staff regret the error.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.